Document is current

Any future updates will be listed below

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease

Crossref DOI link: https://doi.org/10.1186/s13054-020-03055-6

Published Online: 2020-06-08

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark